IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.326
AS - Asia 10.841
EU - Europa 10.190
SA - Sud America 2.108
Continente sconosciuto - Info sul continente non disponibili 895
AF - Africa 291
OC - Oceania 29
Totale 42.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.693
SG - Singapore 5.024
IE - Irlanda 1.748
IT - Italia 1.669
BR - Brasile 1.627
CN - Cina 1.466
UA - Ucraina 1.438
RU - Federazione Russa 1.414
HK - Hong Kong 1.355
VN - Vietnam 1.134
DE - Germania 774
SE - Svezia 756
FR - Francia 661
FI - Finlandia 529
GB - Regno Unito 393
KR - Corea 363
CA - Canada 311
BD - Bangladesh 291
IN - India 234
TR - Turchia 165
AR - Argentina 163
IQ - Iraq 126
NL - Olanda 109
MX - Messico 106
PL - Polonia 106
AT - Austria 105
JP - Giappone 94
RO - Romania 87
CO - Colombia 82
ID - Indonesia 75
ZA - Sudafrica 74
UZ - Uzbekistan 72
PK - Pakistan 71
CH - Svizzera 65
EC - Ecuador 62
ES - Italia 61
VE - Venezuela 61
SA - Arabia Saudita 57
CZ - Repubblica Ceca 50
BE - Belgio 49
CL - Cile 38
CR - Costa Rica 34
PH - Filippine 32
MA - Marocco 31
MY - Malesia 31
EG - Egitto 29
JO - Giordania 27
KE - Kenya 27
PY - Paraguay 26
GR - Grecia 25
JM - Giamaica 25
AE - Emirati Arabi Uniti 24
DZ - Algeria 24
TN - Tunisia 24
LB - Libano 23
LT - Lituania 23
HN - Honduras 22
NI - Nicaragua 21
SV - El Salvador 21
NP - Nepal 19
DK - Danimarca 18
PE - Perù 18
TT - Trinidad e Tobago 18
GT - Guatemala 17
KZ - Kazakistan 16
AZ - Azerbaigian 15
EE - Estonia 15
IL - Israele 15
AL - Albania 14
ET - Etiopia 14
UY - Uruguay 14
AU - Australia 13
BO - Bolivia 13
PT - Portogallo 13
NZ - Nuova Zelanda 12
OM - Oman 12
EU - Europa 11
BG - Bulgaria 10
GP - Guadalupe 10
HR - Croazia 10
IR - Iran 10
PR - Porto Rico 10
TH - Thailandia 10
AM - Armenia 9
KG - Kirghizistan 9
PA - Panama 8
AO - Angola 7
BB - Barbados 7
CW - ???statistics.table.value.countryCode.CW??? 7
PS - Palestinian Territory 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
MD - Moldavia 6
RS - Serbia 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
CI - Costa d'Avorio 5
Totale 41.670
Salva come PNG Salva come JPEG
Città #
Singapore 3.564
Chandler 1.969
Dublin 1.746
San Jose 1.746
Hong Kong 1.339
Ashburn 1.309
San Mateo 851
Jacksonville 753
Boardman 682
Santa Clara 674
Council Bluffs 615
Moscow 522
Dong Ket 479
Altamura 474
Princeton 416
Medford 409
Lauterbourg 396
Perugia 363
Wilmington 359
Beijing 356
Seoul 356
Lawrence 355
Los Angeles 319
Ann Arbor 259
Des Moines 254
New York 251
Munich 229
The Dalles 211
Ho Chi Minh City 209
Andover 184
Dallas 172
Hanoi 160
Piscataway 155
São Paulo 144
Helsinki 131
Phoenix 126
Saint Petersburg 121
Falls Church 94
San Paolo di Civitate 94
Turku 93
Frankfurt am Main 89
Montreal 89
Orem 89
Tokyo 86
Brooklyn 83
Chicago 77
Denver 77
Norwalk 74
Warsaw 69
Rome 68
Woodbridge 67
Atlanta 66
Izmir 66
Houston 65
Nuremberg 65
Chennai 64
Milan 60
Toronto 59
Baghdad 58
London 57
Carrboro 55
Columbus 54
Redmond 54
Amsterdam 51
Buffalo 50
Stockholm 49
Belo Horizonte 48
Shanghai 44
Tashkent 43
Brussels 42
Poplar 41
Boston 40
Johannesburg 40
Manchester 40
Charlotte 39
Rio de Janeiro 39
San Francisco 38
Naples 37
Bucharest 36
Mexico City 36
Timisoara 35
Brasília 34
Vienna 33
Curitiba 31
Da Nang 29
North Bergen 28
San José 28
Haiphong 27
Redwood City 27
Campinas 26
Seattle 26
Istanbul 25
Amman 24
Caracas 23
Florence 23
Guangzhou 23
Lahore 23
Riyadh 23
Miami 22
Nairobi 22
Totale 25.775
Salva come PNG Salva come JPEG
Nome #
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 294
CSF and blood biomarkers for Parkinson's disease 216
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 208
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 173
A new assay for antiphospholipid antibodies in patient with ischemic stroke 169
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 167
a-D-Mannosidses in patients with familial Alzheimer's Disease 164
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 163
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 156
Platelet MAO-B activity and vitamin B12 in old age dementias. 154
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 149
a-D-Mannosidases in patients with Alzheimer's disease 148
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 144
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 142
Hippocampal epileptogenesis in autoimmune encephalitis 141
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 140
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 140
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 139
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 138
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 137
Blood pressure and functional aspects of the aging brain. 137
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 137
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 137
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 137
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 135
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 134
A magnetization transfer study of mild and advanced Parkinson's disease. 134
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 133
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 133
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 133
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 133
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 132
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 132
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 132
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 131
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 131
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 130
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 130
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 130
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 130
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 129
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 129
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 129
Swalloving dysfunction: neurovascolar- anatomical correlation. 128
Cerebrospinal fluid biomarkers in Parkinson disease. 128
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 126
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 126
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 125
Early admission to stroke unit influences clinical outcome 125
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 125
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 125
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 125
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 124
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 124
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 124
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 124
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 123
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 123
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 123
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 123
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 122
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 122
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 121
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 121
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 121
Is multi-infarct dementia representative of vascular dementias? A retrospective study 120
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 120
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 120
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 120
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 119
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 118
[Drinking-water and cardiovascular mortality]. 118
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 118
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 118
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 117
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 117
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 117
Amyloid-β: a potential link between epilepsy and cognitive decline 117
Cannabidiol: metabolism and clinical efficacy in epileptic patients 116
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 116
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 116
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 116
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 116
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 116
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 116
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 115
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 115
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 114
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. 114
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 114
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 114
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 114
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 113
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 113
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 113
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 113
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 112
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 112
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 112
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 112
Totale 13.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 199.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.444 0 0 0 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20256.102 86 606 234 283 761 351 191 456 1.231 417 995 491
2025/202614.247 1.032 1.005 782 1.935 1.889 1.263 2.360 717 1.440 1.119 445 260
2026/20274.427 369 685 949 2.424 0 0 0 0 0 0 0 0
Totale 42.680